Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study

Objectives To evaluate the short-term and long-term prognostic impacts of acute phase coronary collaterals to occluded infarct-related arteries (IRA) after ST-elevation myocardial infarction (STEMI) in the percutaneous coronary intervention (PCI) era. Design A prospective observational study. Setting Osaka Acute Coronary Insufficiency Study (OACIS) in Japan. Participants 3340 patients with STEMI from the OACIS database who were admitted to hospitals within 24 hours from the onset and who had a completely occluded IRA. Interventions Patients were divided into 4 groups according to the Rentrop collateral score (RCS) by angiography on admission (RCS-0, no visible collaterals; RCS-1, collaterals without IRA filling; RCS-2, collaterals with partial IRA filling; and RCS-3, collaterals with complete IRA filling). Primary outcome measures In-hospital and 5-year mortality. Results Patients with RCS-0/3 were older than patients with RCS-1/2, and the prevalence of previous myocardial infarction was highest in patients with RCS-3. Median peak creatinine phosphokinase levels decreased as RCS increases (p<0.001), suggesting the acute cardioprotective effects of collaterals. Although RCS-1 and RCS-2 collaterals were associated with better in-hospital mortality (adjusted OR 0.48, p=0.046 and 0.38, p=0.010 for RCS-1 and RCS-2, respectively) and 5-year mortality (adjusted HR 0.53, p=0.004 and 0.46, p<0.001 for RCS-1 and RCS-2, respectively) as compared with R-0, presence of RCS-3 collaterals was not associated with improved in-hospital (adjusted OR 1.35, p=0.331) and 5-year mortality (adjusted HR 0.98, p=0.920), possibly because worse clinical profiles in patients with RCS-3 may mask mortality benefit of coronary collaterals. Conclusions Presence of acute phase coronary collaterals such as RCS-1 and RCS-2 were associated with better in-hospital and 5-year mortality after STEMI in the contemporary PCI era.

[1]  I. Komuro,et al.  Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker. , 2014, The American journal of cardiology.

[2]  Pascal Meier,et al.  The human coronary collateral circulation: development and clinical importance. , 2013, European heart journal.

[3]  C. Seiler,et al.  The impact of the coronary collateral circulation on mortality: a meta-analysis. , 2012, European heart journal.

[4]  G. Schuler,et al.  Effect of coronary collaterals on long-term prognosis in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction. , 2010, The American journal of cardiology.

[5]  G. Lamas,et al.  Impact of Collateral Flow to the Occluded Infarct-Related Artery on Clinical Outcomes in Patients With Recent Myocardial Infarction: A Report From the Randomized Occluded Artery Trial , 2010, Circulation.

[6]  R. Vogel,et al.  Myocardial Salvage Through Coronary Collateral Growth by Granulocyte Colony-Stimulating Factor in Chronic Coronary Artery Disease: A Controlled Randomized Trial , 2009, Circulation.

[7]  Pascal Meier,et al.  Beneficial Effect of Recruitable Collaterals: A 10-Year Follow-Up Study in Patients With Stable Coronary Artery Disease Undergoing Quantitative Collateral Measurements , 2007, Circulation.

[8]  B. Gersh,et al.  Impact of collateral flow on myocardial reperfusion and infarct size in patients undergoing primary angioplasty for acute myocardial infarction. , 2007, American heart journal.

[9]  M. Hori,et al.  Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[10]  H. Suryapranata,et al.  Clinical and angiographic predictors of outcome after primary angioplasty , 2007 .

[11]  J. Ware,et al.  Therapeutic angiogenesis in cardiovascular disease , 2003, Nature Reviews Drug Discovery.

[12]  D. Antoniucci,et al.  Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. , 2002, The American journal of cardiology.

[13]  J. López-Sendón,et al.  Influence of collateral circulation on in-hospital death from anterior acute myocardial infarction. , 1998, Journal of the American College of Cardiology.

[14]  M. Hori,et al.  Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. , 1997, Journal of the American College of Cardiology.

[15]  Y. Sakata,et al.  Comparison of myocardial contrast echocardiography and coronary angiography for assessing the acute protective effects of collateral recruitment during occlusion of the left anterior descending coronary artery at the time of elective angioplasty. , 1997, The American journal of cardiology.

[16]  M. Hori,et al.  Collateral channels that develop after an acute myocardial infarction prevent subsequent left ventricular dilation. , 1996, Journal of the American College of Cardiology.

[17]  M. Fujita,et al.  Importance of ischemic preconditioning and collateral circulation for left ventricular functional recovery in patients with successful intracoronary thrombolysis for acute myocardial infarction. , 1993, American heart journal.

[18]  R. Gibbons,et al.  Determinants of Infarct Size in Reperfusion Therapy for Acute Myocardial Infarction , 1992, Circulation.

[19]  B. G. Brown,et al.  Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. , 1991, Circulation.

[20]  S Sasayama,et al.  Importance of collateral circulation for prevention of left ventricular aneurysm formation in acute myocardial infarction. , 1989, Circulation.

[21]  Dwight E. Peake,et al.  Thrombolysis in myocardial infarction (TIMI) trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase , 1988 .

[22]  R Roberts,et al.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.

[23]  M. Cohen,et al.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. , 1985, Journal of the American College of Cardiology.

[24]  A. Ross,et al.  Temporal evolution of the human coronary collateral circulation after myocardial infarction. , 1984, Journal of the American College of Cardiology.

[25]  J. Kasprzak,et al.  Presence of coronary collaterals in ST-elevation myocardial infarction patients does not affect long-term outcome. , 2013, Polskie Archiwum Medycyny Wewnetrznej.

[26]  M. Hori,et al.  Effect of pre-reperfusion residual flow on recovery from myocardial stunning: a myocardial contrast echocardiography study. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[27]  Harold T. Dodge,et al.  Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .